Waters (NYSE:WAT – Get Rating) issued an update on its second quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus estimate of $2.77. Waters also updated its FY22 guidance to $11.90-12.10 EPS.
A number of brokerages have issued reports on WAT. SVB Leerink lowered their price target on Waters from $375.00 to $350.00 and set a market perform rating on the stock in a research report on Wednesday, February 2nd. Wells Fargo & Company upgraded Waters from an underweight rating to an equal weight rating and decreased their target price for the company from $320.00 to $315.00 in a research report on Monday, April 25th. Finally, StockNews.com initiated coverage on shares of Waters in a report on Thursday, March 31st. They issued a buy rating for the company. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and a consensus target price of $373.83.
Shares of NYSE:WAT opened at $302.38 on Tuesday. The company has a debt-to-equity ratio of 4.12, a current ratio of 2.39 and a quick ratio of 1.87. Waters has a 1 year low of $288.32 and a 1 year high of $428.22. The firm has a market capitalization of $18.26 billion, a PE ratio of 27.05, a P/E/G ratio of 3.02 and a beta of 0.85. The business’s 50 day moving average price is $313.05 and its 200-day moving average price is $331.66.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Penserra Capital Management LLC grew its stake in Waters by 22.0% during the 4th quarter. Penserra Capital Management LLC now owns 272 shares of the medical instruments supplier’s stock valued at $101,000 after acquiring an additional 49 shares in the last quarter. Kingsview Wealth Management LLC boosted its holdings in shares of Waters by 25.6% during the 4th quarter. Kingsview Wealth Management LLC now owns 810 shares of the medical instruments supplier’s stock worth $302,000 after purchasing an additional 165 shares during the last quarter. Advisors Asset Management Inc. grew its position in shares of Waters by 3.7% in the fourth quarter. Advisors Asset Management Inc. now owns 6,788 shares of the medical instruments supplier’s stock valued at $2,529,000 after purchasing an additional 242 shares in the last quarter. Toroso Investments LLC increased its holdings in shares of Waters by 25.1% in the fourth quarter. Toroso Investments LLC now owns 1,402 shares of the medical instruments supplier’s stock valued at $522,000 after purchasing an additional 281 shares during the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new position in Waters during the fourth quarter worth approximately $202,000. Hedge funds and other institutional investors own 90.65% of the company’s stock.
About Waters (Get Rating)
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
- Get a free copy of the StockNews.com research report on Waters (WAT)
- Tractor Supply Stock Should Plow Ahead
- MarketBeat Podcast: Investing In Innovation, Robotics, AI and Healthcare
- Saia Growth Accelerates But It May Not Matter
- It’s Time to Book an Appointment for Teladoc Stock
- GitLab Stock is Trying to Put in a Bottom Here
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.